과제정보
The authors would like to thank the Director and Head of School, MIT School of Bioengineering Sciences & Research for giving an opportunity to work independently and all there support with the best lab facilities.
참고문헌
- Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed 2020;91:157-160.
- World Health Organization. Geneva: World Health Organization, 2022. Accessed 2022 Nov 30. Available from: https://www.who.int/.
- Aslan A, Aslan C, Zolbanin NM, Jafari R. Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management. Pneumonia (Nathan) 2021;13:14.
- Tzotzos SJ, Fischer B, Fischer H, Zeitlinger M. Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey. Crit Care 2020;24:516.
- Li X, Ma X. Acute respiratory failure in COVID-19: is it "typical" ARDS? Crit Care 2020;24:198.
- ARDS Definition Task Force; Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012;307:2526-2533.
- Peck TJ, Hibbert KA. Recent advances in the understanding and management of ARDS. F1000Res 2019;8:F1000 Faculty Rev1959.
- Menk M, Estenssoro E, Sahetya SK, Neto AS, Sinha P, Slutsky AS, et al. Current and evolving standards of care for patients with ARDS. Intensive Care Med 2020;46:2157-2167. https://doi.org/10.1007/s00134-020-06299-6
- Brower RG, Ware LB, Berthiaume Y, Matthay MA. Treatment of ARDS. Chest 2001;120:1347-1367. https://doi.org/10.1378/chest.120.4.1347
- Boyle AJ, Mac Sweeney R, McAuley DF. Pharmacological treatments in ARDS: a state-of-the-art update. BMC Med 2013;11:166.
- Malin JJ, Suarez I, Priesner V, Fatkenheuer G, Rybniker J. Remdesivir against COVID-19 and other viral diseases. Clin Microbiol Rev 2020;34:e00162-20.
- Wong JJ, Leong JY, Lee JH, Albani S, Yeo JG. Insights into the immuno-pathogenesis of acute respiratory distress syndrome. Ann Transl Med 2019;7:504.
- Zheng F, Pan Y, Yang Y, Zeng C, Fang X, Shu Q, et al. Novel biomarkers for acute respiratory distress syndrome: genetics, epigenetics and transcriptomics. Biomark Med 2022;16:217-231. https://doi.org/10.2217/bmm-2021-0749
- Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. J Adv Res 2020;24:91-98. https://doi.org/10.1016/j.jare.2020.03.005
- Chen X, Kang Y, Luo J, Pang K, Xu X, Wu J, et al. Next-generation sequencing reveals the progression of COVID-19. Front Cell Infect Microbiol 2021;11:632490.
- Hu J, Li C, Wang S, Li T, Zhang H. Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data. Hum Genomics 2021;15:10.
- Upadhyai P, Shenoy PU, Banjan B, Albeshr MF, Mahboob S, Manzoor I, et al. Exome-wide association study reveals host genetic variants likely associated with the severity of COVID-19 in patients of European ancestry. Life (Basel) 2022;12:1300.
- Puckelwartz MJ, Pesce LL, Nelakuditi V, Dellefave-Castillo L, Golbus JR, Day SM, et al. Supercomputing for the parallelization of whole genome analysis. Bioinformatics 2014;30:1508-1513. https://doi.org/10.1093/bioinformatics/btu071
- Chauhan AJ, Wiffen LJ, Brown TP. COVID-19: a collision of complement, coagulation and inflammatory pathways. J Thromb Haemost 2020;18:2110-2117. https://doi.org/10.1111/jth.14981
- Yadav H, Thompson BT, Gajic O. Fifty years of tesearch in ARDS: is acute respiratory distress syndrome a preventable disease? Am J Respir Crit Care Med 2017;195:725-736. https://doi.org/10.1164/rccm.201609-1767CI
- National Center for Biotechnology Information. Bethesda: National Center for Biotechnology Information, 2022. Accessed 2022 Dec 15. Available from: https://www.ncbi.nlm.nih.gov/.
- SRA - NCBI. Bethesda: National Library of Medicine, 2022. Accessed 2022 Dec 15. Available from: https://www.ncbi.nlm.nih.gov/sra/.
- EMBL-EBI. Variant identification and analysis. Variant identification and analysis. Cambridgeshire: EMBL-EBI, 2022. Accessed 2022 Dec 15. Available from: https://www.ebi.ac.uk/training/ online/courses/human-genetic-variation-introduction/variant-identification-and-analysis/.
- Galaxy. Galaxy Community, 2022. Accessed 2022 Dec 15. Available from: https://usegalaxy.org/.
- Saif R, Ejaz A, Mehmood T, Asif F, Alghanem SM, Ahmad TS. Introduction to galaxy platform for NGS variant calling pipeline. Adv Life Sci 2020;7:129-134.
- What is FastQC. Cambridgeshire: Babraham Institute, 2013. Accessed 2022 Dec 15. Available from: https://www.bioinformatics.babraham.ac.uk/projects/fastqc/Help/1%20Introduction/1.1%20What%20is%20FastQC.html.
- Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. Nat Methods 2015;12:357-360. https://doi.org/10.1038/nmeth.3317
- Robinson JT, Thoraldsdottir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol 2011;29:24-26. https://doi.org/10.1038/nbt.1754
- Integrative Genomics Viewer. Oakland: Broad Institute and the Regents of the University of California, c2013-2021. Accessed 2022 Dec 15. Available from: https://software.broadinstitute.org/software/igv/.
- Bukowski R, Sun Q, Wang M. Variant Calling part 1 (Galaxy) - Bioinformatics Documentation. North Melbourne: Melbourne Bioinformatics, 2022. Accessed 2022 Dec 15. Available from: https://melbournebioinformatics.github.io/MelBioInf_docs/tutorials/var_detect_advanced/var_detect_advanced/.
- Introduction. SnpEff & SnpSift Documentation, 2012. Accessed 2022 Dec 15. Available from: http://pcingola.github.io/SnpEff/se_introduction/.
- Variant Calling part 2 (Galaxy) - Bioinformatics Documentation. North Melbourne: Melbourne Bioinformatics, 2022. Accessed 2022 Dec 15. Available from: https://melbournebioinformatics.github.io/MelBioInf_docs/tutorials/var_detect_advanced/ var_detect_advanced/.
- Zhang Y, Qin L, Zhao Y, Zhang P, Xu B, Li K, et al. Interferon-induced transmembrane protein 3 genetic variant rs12252-C associated with disease severity in coronavirus disease 2019. J Infect Dis 2020;222:34-37. https://doi.org/10.1093/infdis/jiaa224
- Zong Y, Li X. Identification of causal genes of COVID-19 using the SMR method. Front Genet 2021;12:690349.
- Aboudounya MM, Heads RJ. COVID-19 and Toll-like receptor 4 (TLR4): SARS-CoV-2 may bind and activate TLR4 to increase ACE2 expression, facilitating entry and causing hyperinflammation. Mediators Inflamm 2021;2021:8874339.
- Ali HN, Niranji SS, Al-Jaf SM. Association of Toll-like receptor-4 polymorphism with SARS CoV-2 infection in Kurdish population. Human Gene 2022;34:201115.